Previous 10 | Next 10 |
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors PR Newswire DUBLIN , March 7, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Nancy S. Lurker, to the company's Board of Di...
2024-02-21 13:04:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks are often at the forefront of innovation. These are the companies we hear about that are driving breakthroughs in healthcare. Essentially, they are responsible for improving ...
2024-02-20 12:32:42 ET More on Alkermes Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage Alkermes to sell Athlone facility in Ireland to Novo Nordisk for $92.5M Alkermes Q4 2023 Earnings Preview Alkermes plc 2023 Q4 - Results - Earnin...
2024-02-18 05:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-16 11:10:43 ET More on iShares Russell 2000 ETF: IWM: Technical Analysis Says You Should Buy Small Caps IWM: Supply-Side Disinflation Benefits Small Caps The Most Small-Cap ETFs: Performance, Fundamentals, And Rankings For 102 Funds Investors retract ...
2024-02-15 15:08:12 ET Alkermes plc (ALKS) Q4 2023 Earnings Conference Call February 15, 2024, 08:00 AM ET Company Participants Sandra Coombs - Senior Vice President, Corporate Affairs and Investor Relations Richard Pops - Chairman and Chief Executive Officer Tod...
2024-02-15 07:07:23 ET More on Alkermes Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet Alkermes Q4 2023 Earnings Preview Alkermes to sell Athlone facility in Ireland to...
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024 PR Newswire — Total Revenues of $1.66 Billion in 2023; Net Sales of Proprietary Products Increased Approximately 18% Year-Over-Yea...
Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...
2024-02-14 11:25:34 ET More on Alkermes Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet Alkermes to sell Athlone facility in Ireland to Novo Nordisk for $92.5M Seeking A...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...